Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ProPhase Labs (PRPH) Gross Margin (2016 - 2025)

Historic Gross Margin for ProPhase Labs (PRPH) over the last 16 years, with Q3 2025 value amounting to 13.93%.

  • ProPhase Labs' Gross Margin fell 291100.0% to 13.93% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.41%, marking a year-over-year decrease of 5945500.0%. This contributed to the annual value of 2.21% for FY2024, which is 466500.0% down from last year.
  • Per ProPhase Labs' latest filing, its Gross Margin stood at 13.93% for Q3 2025, which was down 291100.0% from 58.86% recorded in Q2 2025.
  • Over the past 5 years, ProPhase Labs' Gross Margin peaked at 64.35% during Q2 2022, and registered a low of 13.93% during Q3 2025.
  • Moreover, its 5-year median value for Gross Margin was 48.85% (2021), whereas its average is 36.76%.
  • As far as peak fluctuations go, ProPhase Labs' Gross Margin crashed by -733800bps in 2024, and later surged by 691700bps in 2025.
  • Over the past 5 years, ProPhase Labs' Gross Margin (Quarter) stood at 54.52% in 2021, then dropped by -5bps to 51.7% in 2022, then grew by 23bps to 63.53% in 2023, then crashed by -115bps to 9.84% in 2024, then tumbled by -42bps to 13.93% in 2025.
  • Its Gross Margin was 13.93% in Q3 2025, compared to 58.86% in Q2 2025 and 36.76% in Q1 2025.